Kim P. Kamdar - Aug 11, 2023 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Aug 11, 2023
Transactions value $
-$361,986
Form type
4
Date filed
8/15/2023, 07:17 PM
Previous filing
Jul 7, 2023
Next filing
Dec 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Sale -$211K -354K -8.05% $0.60 4.04M Aug 11, 2023 By Domain Partners IX, L.P. F1, F2, F3
transaction OMIC Common Stock Sale -$44.4K -78K -1.93% $0.57 3.96M Aug 14, 2023 By Domain Partners IX, L.P. F1, F3, F4
transaction OMIC Common Stock Sale -$107K -200K -5.05% $0.53 3.76M Aug 15, 2023 By Domain Partners IX, L.P. F1, F3, F5
holding OMIC Common Stock 15K Aug 11, 2023 By Domain Associates, LLC F3
holding OMIC Common Stock 15K Aug 11, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Domain Partners IX, L.P. has been an investor in the Issuer since 2016 and continues to hold 3,763,985 shares of the Issuer's common stock.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.58 to $0.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
F3 The Reporting Person is a managing member of Domain Associates, LLC and of One Partner Square Associates IX, LLC, the sole general partner of Domain Partners IX, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity; however, she disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed her pecuniary interest therein and/or that are not actually distributed to her.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.5821, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 4 to this Form 4.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.53 to $0.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 5 to this Form 4.